Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Interview of the week

Interview: Dr Andrew Whiteley, Lexacom

Lexacom is a UK-based company that provides AI-based scribe tools for clinicians to automate note-taking. This is a space with a lot of competition at the moment, with a lot of venture capital money funding new startups. However, with 25 years of experience under its belt, Lexacom has managed to achieve a dominant position in the UK market. HBI spoke to Dr Andrew Whiteley, the company’s founder, about what differentiates Lexacom from its numerous competitors, the NHS’ recent decision to require scribes to be certified as medical devices, and Lexacom’s growing international presence.

Interview: Amethyst’s Stéphane Carré on Fremman Capital deal, European expansion, and radiotherapy investment

HBI spoke with Amethyst CEO Stéphane Carré about the new partnership, expansion plans, the investment climate in radiotherapy, and the role of public-private partnerships in Amethyst’s model.

Are investors and Academic Medical Centres a perfect match? In conversation with Nexus Gulf Healthcare’s Renan Baroukh

In an increasingly competitive and constrained healthcare landscape, in which local opportunities to grow and seek investment are becoming more difficult, Academic Medical Centres (AMC) are increasingly pursuing international expansion and investment partnerships in emerging healthcare markets.  Renan Baroukh, Chief Finance & Investment Officer at Nexus Gulf Healthcare, a specialised healthcare investment and development platform […]

Exploring Saudi Arabia’s “completely different universe” for healthcare investors, with Youssef Haidar of Nexus Gulf

This interview features in the HBI 2025: Disruptive Innovation: Investing in Healthcare Transformation Conference Report, which was shared with conference delegates, and is available to HBI Deals and Insights and Intelligence members. Saudi Arabia’s rapidly developing private healthcare sector offers significant opportunities for international providers prepared to enter the country with the right partnerships, according […]

How AI can reduce face-to-face appointments by 60+% — an interview with Richard Armitage, Ufonia

Ufonia is a UK digital health company that has developed an AI tool that can automate conversations which would normally take place with a clinician. In an interview with HBI, Richard Armitage, Ufonia’s new Commercial Director, explained the huge potential of this technology.

Interview: Exploring NHS market reforms and the UK healthcare investment landscape with Sharon Lamb, Partner at McDermott Will & Emery

With record NHS waiting lists and major structural reforms underway, private healthcare investment in the UK continues to show resilience amidst broader economic uncertainties. Recent government action to transform the NHS are creating new market dynamics, yet investor appetite remains strong, particularly in subsectors serving patients seeking alternatives to lengthy NHS queues. HBI spoke with […]

Why AI will play a central role in drug discovery — in conversation with Boston Consulting Group’s Chris Meier 

Drug discovery is important, but the process is often slow, expensive, and risky.  According to a report by Boston Consulting Group (BCG), an American global management consulting firm, on average, it typically takes 12 to 15 years and about $2.5 billion to bring a single drug to market. Only 9 to 14% of drugs that […]

How can ophthalmology groups across the globe successfully boost growth and value creation? — in conversation with ZEISS

Demand in ophthalmology is growing, driven by an ageing population and a rise in eye-related conditions. This, coupled with exciting new technologies, personalised care solutions, and advances in cataract and refractive surgery, means national and international groups are expanding. HBI spoke with Ana Neves and Michael Achtelik from ZEISS Medical Technology for some initial insights ahead of HBI 2025 on strategies for growth and value creation for ophthalmology groups in different markets across the globe, how international operators can drive commercial and operational excellence, and what technology’s role is in driving performance.

‘Clients are ready to pay if the service is right’ — Daniel Einhorn on the recipe for growth in veterinary care

A veterinary services business is fast becoming a ‘must have’ for every private equity healthcare portfolio. And with that in mind, HBI spoke with Daniel Einhorn, founder and former CEO of French veterinary services provider Sevetys, to better understand why they are such a compelling addition.

“AI should be seen as a tool, not a solution on its own” – in conversation with Martin Møller Paarse, COO, Liva Healthcare

In early February 2025, Liva Healthcare, a UK-based digital health company, acquired Discover Momenta and its subsidiary, Momenta Newcastle, for an undisclosed sum. Liva offers human-led therapeutic intervention programmes aimed at addressing chronic lifestyle diseases, such as type 2 diabetes. HBI caught up with Martin Møller Paarse, COO of Liva Healthcare, to explore the evolving digital healthcare landscape in the UK and Europe, along with investment opportunities, market consolidation, and Liva’s mission in the sector.

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us